Skip to main content
Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.690
+0.240 (16.55%)
At close: Apr 9, 2025, 4:00 PM
1.600
-0.090 (-5.33%)
Pre-market: Apr 10, 2025, 4:07 AM EDT

Q32 Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--6.656.65-
Cost of Revenue
48.1431.7335.8129.93
Gross Profit
-48.14-38.38-29.16-29.93
Selling, General & Admin
17.969.8810.066.76
Operating Expenses
17.969.8810.066.76
Operating Income
-66.1-48.26-39.23-36.69
Interest Expense
-1.4-2--
Interest & Investment Income
3.9---
Earnings From Equity Investments
-1.63---
Other Non Operating Income (Expenses)
2.33.02-3.52-0.32
EBT Excluding Unusual Items
-62.93-47.23-42.75-37.02
Gain (Loss) on Sale of Investments
-0.68---
Other Unusual Items
15.89-6.19--
Pretax Income
-47.71-53.43-42.75-37.02
Income Tax Expense
0.020.320.060.55
Net Income
-47.73-53.74-42.81-37.56
Net Income to Common
-47.73-53.74-42.81-37.56
Shares Outstanding (Basic)
9076
Shares Outstanding (Diluted)
10076
Shares Change (YoY)
2666.77%-95.03%8.57%-
EPS (Basic)
-5.12-153.96-6.09-5.81
EPS (Diluted)
-6.58-153.96-6.09-5.81
Free Cash Flow
-67.79-18.68-13.44-33.14
Free Cash Flow Per Share
-7.02-53.52-1.91-5.12
Operating Margin
---589.76%-
Profit Margin
---643.65%-
Free Cash Flow Margin
---202.10%-
EBITDA
-65.62-47.76-38.86-36.65
D&A For EBITDA
0.490.50.370.05
EBIT
-66.1-48.26-39.23-36.69
Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q